RE: Gout and sodium‐glucose cotransporter‐2 inhibitors

Early View

LETTER TO THE EDITOR

Lars Christian Lund,

Corresponding Author

Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark

Correspondence

Lars Christian Lund, Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, J.B. Winsløws Vej 19, 2, 5000 Odense C, Denmark.

Email: lclund@health.sdu.dk

Search for more papers by this authorMikkel Højlund,

Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark

Search for more papers by this authorDaniel Pilsgaard Henriksen,

Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark

Search for more papers by this authorJesper Hallas,

Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark

Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark

Search for more papers by this authorKasper Bruun Kristensen,

Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark

Search for more papers by this author PDFPDF Please review our Terms and Conditions of Use and check box below to share full-text version of article.

I have read and accept the Wiley Online Library Terms and Conditions of Use

Shareable Link

Use the link below to share a full-text version of this article with your friends and colleagues. Learn more.

Share a link

Share on

No abstract is available for this article.

留言 (0)

沒有登入
gif